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A B S T R A C T
Clinical, epidemiological and laboratory findings of four patients with subacute sclerosing panencephalitis (SSPE),
diagnosed in Croatia in 2002, were examined. Patient age at disease onset ranged from 5–11 years. All patients were vac-
cinated regularly with MMR-vaccine. Two patients had a history of measles infection at the age of six and seven months,
respectively. In the other two patients, the disease started immediately after the varicella infection. Complement fixing
antibody titre to the measles virus (MV) ranged from 1:1024 to 1:65536 in serum, and from 1:16 to 1:128 in cerebrospinal
fluid (CSF). In CSF, no antibodies to varicella-zoster virus were found. Brain tissue samples were obtained at autopsy
from two patients. In one patient, electron microscopy demonstrated intranuclear viral inclusions (MV nucleocapsids).
MV antigen was detected in brain imprints using IFA in both of them. Viral RNA was found in brain tissue samples only,
while plasma, serum and CSF were negative. Nucleotide sequence analysis showed that the viruses detected in brain tis-
sue belong to the wild-type MV D6 genotype14.
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Introduction
Subacute sclerosing panencephalitis (SSPE) is a rare,
fatal, and late complication of measles. Although SSPE
rates reported in the literature vary, it is estimated that
approximately one case of SSPE occurs per 10,000 to
1,000,000 reported measles cases1–3. The disease occurs
5–10 years after the initial attack of measles. Mental de-
terioration and myoclonus usually characterize the dis-
ease onset, leading to a vegetative, decorticated state,
coma and death within 1–3 years. In approximately 10%
of cases, there is a fulminant course with death few
months after the onset4. The exact pathogenic mecha-
nism of SSPE remains unclear. While large amounts of
measles antigens are present within inclusion bodies in
infected brain cells, no virus particles mature. Viral repli-
cation is defective owing to the lack of production of one
or more viral gene products, often the matrix protein5. It
is unknown whether there is a specific predisposing im-
mune defect. A possible risk factor for the development of
SSPE is measles infection at an early age, especially be-
fore the age of two years6. Demonstration of intrathecal
measles virus (MV)-specific antibody synthesis or detec-
tion of MV-RNA from brain tissue confirms diagnosis7.
We describe the four SSPE cases diagnosed in Croatia
in 2002.
Case Reports
Patient 1
Patient 1 was born in December 1997 in a very high-
risk twin pregnancy. She was vaccinated regularly with
the measles-mumps-rubella (MMR)-vaccine according to
the official immunization schedule8. At the age of six
months, she was hospitalized for morbilliform rash. In
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August 2002, she developed dysarthria, ataxia and myo-
clonal jerks. The electroencephalogram (EEG) showed
diffuse paroxysmal discharges accompanied by sharp-
wave complexes and valproate therapy was started. Com-
puted tomography (CT) of the brain was normal. Be-
cause of persistent seizures, the girl was admitted to the
hospital. CSF analysis revealed the IgG synthesis within
the central nervous system (CNS) with oligoclonal bands
of immunoglobulins. Repeated CT of the brain revealed
diffuse atrophic changes. Despite being on valproate
therapy she experienced no improvement. The girl’s con-
dition continued deteriorating. She became soporiferous
and tetraparetic. The disease had a fulminant course and
the girl died in December 2002. Her identical twin sister
also had a morbilliform rash at the age of six months but
she didn't exhibit any symptoms of SSPE until the end of
2004.
Patient 2
Patient 2 was born in November 1994 in a normal
pregnancy. He was vaccinated regularly with the MMR-
vaccine8. At the age of seven months, the boy had a fe-
brile disease with morbilliform rash. During 1995, he
was hospitalized on three occasions for febrile convul-
sions for which he was placed on prophylactic therapy
with phenobarbitone. In October 1996, the boy was read-
mitted to the hospital for relapsing convulsions. Because
of multifocal EEG discharges, he was placed on valproate
therapy. In September 2001, he entered the primary
school. Eight months later, mental deterioration started
accompanied by memory dysfunction, dysgraphia and
dyslexia. Two months later, he developed ataxia and was
admitted to the hospital. EEG revealed hypsarrhythmia.
CSF analysis revealed the IgG synthesis within the CNS
with oligoclonal bands of immunoglobulins. CT of the
brain was normal. A topiramate therapy was started.
During the hospitalization, he still occasionally had par-
tial seizures in the extremities accompanied by short
losses of consciousness and absences. His condition con-
tinued deteriorating. The patient was unable to sit vol-
untarily, stopped talking and lost control of the sphin-
cters. As the disease was progressive, the boy died in
January 2003.
Patient 3
Patient 3 was born in May 1990 in a normal preg-
nancy. He was vaccinated regularly with the MMR-vac-
cine8. At the age of six years, he had the first partial sei-
zure. The EEG revealed dysrrhythmic discharges and a
therapy with primidone was started. In March 2002, he
was hospitalized for varicella when the first generalized
seizure occurred. On an EEG, irritative bilateral changes
were then detected. CT of the brain was normal. Five
months later, his mother noted changes in his behavior,
ataxia and occasionally indistinct speech. The boy was
readmitted to the hospital. At the end of August 2002, he
developed the signs of milder respiratory infection. The
following day he became febrile and markedly somno-
lent, waking up only at a stronger stimulus. Repeated
EEG showed generalized dysrrhythmic discharges with
paroxysms of high-voltage slow waves and occasional
sharp-pointed waves. CSF analysis revealed the IgG syn-
thesis within the CNS with oligoclonal bands of immuno-
globulins. MRI of the brain was normal. On several occa-
sions during the hospitalization, he suffered from gene-
ralized convulsions. A therapy with phenobarbitone and
carbamazepine produced no improvement. The disease
had a progressive course and the boy died in November
2003.
Patient 4
Patient 4 was born in November 1997 in a normal
pregnancy. He was vaccinated regularly with the MMR-
vaccine8. The patient developed varicella in October
2002. On the third day of the disease, his mother noted
his head dropping down on several occasions. The pa-
tient was hospitalized and treated with acyclovir intrave-
nously. Then ataxia and myoclonic seizures of the arm
and head developed. The treatment with carbamazepine
resulted in temporary improvement. Next dyplopia arose
accompanied by dysarthria, swallowing difficulties and
inability to control the sphincters. EEG showed continu-
ous slowness with paroxysmal discharges. CSF analysis
revealed the IgG synthesis within the CNS with oligoclo-
nal bands of immunoglobulins. On brain MRI, discrete
hyperintensive lacunar regions subcortically in white
matter were found. During hospitalization he was treat-
ed with phenobarbitone and carbamazepine but no im-
provement was observed. Due to progressive disease, the
boy died in December 2003.
Methods
Serologic testing of serum and CSF samples for MV
and for varicella zoster virus (VZV)-specific antibodies
was performed at WHO National Measles Laboratory,
Croatian National Institute of Public Health (CNIPH).
Antibody titer was determined by using the complement
fixation (CF) test (micromethod)9 and enzyme-immuno-
sorbent assay (Measles Virus-EIA, Institute Virion; Anti-
VZV-ELISA, Euroimmun). Antigen used in CF test was
obtained from Edmonston strain of MV at Virology De-
partment, CNIPH9. Guinea-pig complement and haemo-
lysin were prepared commercially at the Institute of Im-
munology, Zagreb. Brain tissue samples of two patients
obtained at autopsy were examined by light microscopy,
electron microscopy (EM; Neuropathology Department,
Clinical Hospital Centre, Zagreb) and indirect immuno-
fluorescence (IFA – Measles IFA Kit, Light Diagnostics;
Virology Department, CNIPH).
Results
In 2002, SSPE was diagnosed in four patients (three
boys and one girl) in Croatia. Their age at disease onset
ranged from 5–11 years. They all had been vaccinated
regularly against measles according to the official immu-
nization schedule8. Two had a history of measles infec-
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tion (diagnosed clinically) at the age of six and seven
months, respectively (Table 1). In the other two patients,
the disease began immediately after varicella infection.
We detected antibodies to MV in the CSF and serum of
all patients. The CF-antibody titers ranged from 1:1024
to 1:65536 in serum and from 1:16 to 1:128 in CSF (Table
2). In CSF, no antibodies to VZV were found. For two pa-
tients brain tissue was obtained post mortally. Using
IFA, the MV antigen was detected in the brain imprints
of both patients (Table 2). The histopathologic examina-
tion of the brain tissue from the second patient revealed
neurofibrillar degeneration with acidophil intranuclear
inclusions in the neurons (Figure 1a) and glial cells (Fig-
ure 1b). Using EM, intranuclear viral inclusions com-
posed of MV nucleocapsids were demonstrated (Figure 1c
and 1d). Strong autolysis prevented finding the charac-
teristic changes in the brain tissue from the first patient
(Table 2).
Discussion
The incidence of acute measles infection and SSPE
has been dramatically reduced because of the widespread
administration of measles vaccine. Despite vaccination,
mainland Croatia had two measles outbreaks in the past
ten years with 697 and 648 cases notified in 1995 and
1998, respectively (data from Reference Epidemiology
Centre, CNIPH). The last registered SSPE case before
those reported in the present study dates from 1994.
Studies involving the genetic characterization of viral
material from brain tissue of SSPE patients have all re-
ported the wild type MV10–13. In plasma, serum and CSF
samples of our patients, the RT-PCR revealed no viral
RNA. Only brain tissue samples from both of them were
positive. The nucleotide sequence analysis showed that
viruses detected from the brain tissue belong to the
wild-type MV D6 genotype14.
In spite of some reports of SSPE occurring after the
administration of the MMR vaccine3, 15, there is no evi-
dence that the measles vaccine could cause SSPE (no
vaccine strain has ever been discovered). Similarly, no in-
creased risk associated with the administration of a mea-
sles vaccine to the children who had already had measles
was observed16. It is likely that SSPE cases with no his-
tory of natural measles infection may have resulted from
a subclinical or unrecognized infection that occurred be-
fore the administration of vaccine17. Before the routine
use of measles vaccine, Krugman et al. reported finding
that 15–20% of the children whose parents had reported
no history of measles were immune to this disease. These
children presumably were exposed at a time when mater-
nal antibodies modified the disease but did not prevent
asymptomatic or non-specific infection18. The other pos-
sibility of SSPE in vaccinated individuals is due to poor
seroconversion or vaccine failure. This could happen ei-
ther due to poor quality of vaccine or to its administra-
tion at an earlier than the recommended age at 12–15
months19.
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TABLE 1
CLINICAL AND EPIDEMIOLOGICAL DATA OF FOUR SSPE PATIENTS
Patients Sex
Year of
birth
Place of
birth
MMR-vaccination
/revaccination (age)
Measles infec-
tion (age)
Date of
SSPE onset
Age at
diagnosis
Duration
of disease
1 F 1997 Po`ega 13 mo / –
6 mo (morbilli-
form rash)
August 2002 4 yr 8 mo 4 mo
2 M 1994 Koprivnica
20 mo (only
measles) / 6 yr
7 mo (morbilli-
form rash + fever)
May 2002 7 yr 6 mo 8 mo
3 M 1990 Rovi{}e 12 mo / 11 yr – August 2002 11 yr 3 mo 15 mo
3 M 1997 Gar~in 12 mo / – – October 2002 4 yr 11 mo 14 mo
mo – months
TABLE 2
LABORATORY AND HISTOPATHOLOGIC FINDINGS OF FOUR SSPE PATIENTS
Patients
Complement-fixing test
CSF / serum
EIA – IgG
CSF / serum
Electron microscopy
(brain tissue)
IFA
(brain
imprint)
1
I 1:128
II 1:128
1:32768
1:65536
positive
positive
positive
positive
autolysis, without MV nucleocapsids positive
2
I 1:16
II 1:32
1:4096
1:4096
positive
positive
positive
positive
intranuclear inclusions (MV nucleo-
capsids) in neurons and astrocytes
positive
3 I 1:16 1:1024 positive positive – –
4 I 1:32 1:2048 positive positive – –
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In 2002 in northwest Croatia, an exceptional cluster
of four SSPE patients was diagnosed in a 6-month pe-
riod. They all were vaccinated regularly against measles
at an age of 12–20 months9. Two patients had measles as
infants at the age of six and seven months, respectively,
during the 1998 and 1995 measles outbreaks. In both pa-
tients, the disease was diagnosed retrospectively after
taking detailed medical histories, but was no serologic
confirmation. No vaccine strain was detected in the brain
tissue although both these patients were immunized af-
ter a natural measles infection. According to the reports
of other authors10–13, they have been infected with the
wild-type MV before vaccination14. In the other two
cases, the disease began immediately after a varicella in-
fection. No antibodies to VZV were found in the CSF of
these patients. Anlar et al. have investigated the hypoth-
esis of other viruses contributing to the pathogenesis of
SSPE. They tested the CSF of 43 SSPE patients for
DNA, RNA and antibodies against several viruses, VZV
included, comparing them with those from 39 patients
with other non-infectious neurological disorders. Forty-
one point eight percent of SSPE patients had antibodies
to more than one virus synthesized intrathecally. VZV
DNA was found in 11.6% patients with SSPE compared
to 15.3% in controls. Likewise, antibodies to VZV were
present in 10.2% of SSPE patients and in 10.0% of con-
trols. Their data do not support a specific role for this
agent in SSPE20.
Although the pathogenic mechanisms that result in
SSPE following measles are not understood, several the-
ories are proposed. One theory holds that affected pa-
tients have a hyperimmune response21 resulting in anti-
bodies masking the infected cell surface antigens and
making them unrecognizable to cytotoxic T-cells2. An-
other theory suggests that neurons and glia fail to enve-
lope and transport the antigen to the membrane, leading
to an inability by the immune system to recognize in-
fected cells22.
There have been several reports in the literature
about SSPE in twins. Vieker at al.6 reported the occur-
rence of SSPE in two brothers two years after measles
infection. The occurrence of two cases in one family is
suggestive of a genetic predisposing factor. In contrast,
Dhib-Jalbut and Haddad23 described SSPE in one mem-
ber of identical twins that emphasizes the importance of
other factors in the pathogenesis of SSPE. One our pa-
tient was born in a twin-pregnancy. Her identical twin
sister was also vaccinated against measles after a natural
measles infection at the age of six months but she didn't
exhibit any symptoms of SSPE.
Because SSPE reporting to the Epidemiological Ser-
vice in Croatia is not obligatory, its incidence is un-
known. This study describes a cluster of four SSPE pa-
tients in 2002 in Croatia, after an eight-year interval
with none reported. The last notified diagnosed case of
SSPE was a 10-year old girl in 1994. She had a short pe-
riod of disease progression, but remained stable long
thereafter. Still alive, she suffers from severe neurologi-
cal defects (spastic tetraparesis, blindness and aphasia).
The rate of SSPE in Croatia during observing period is
higher than reported worldwide. We suppose that many
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Fig. 1. Neuron contains eosinophilic nuclear inclusion (a), nuclear inclusion is also in glial cell (b). On electron microscope analysis,
intranuclear viral inclusions are composed of measles virus (MV) nucleocapsids (c and d).
U:\coll-antropolo\coll-antro-4-2006\vilibic.vp
20. prosinac 2006 10:35:38
Color profile: Disabled
Composite  150 lpi at 45 degrees
cases of measles were missed or not reported to the Epi-
demiological Service during the epidemics.
In conclusion, we feel that all SSPE case reporting
should be mandatory and supported by laboratory confir-
mation and molecular characterization of the MV strains.
In addition, all cases of febrile disease accompanied by
morbilliform rash in early childhood in the differential
diagnosis should consider measles.
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SUBAKUTNI SKLEROZIRAJU]I PANENCEFALITIS: STALNA PRIJETNJA
S A @ E T A K
Analizirani su klini~ki, epidemiolo{ki i laboratorijski nalazi ~etvero bolesnika sa subakutnim skleroziraju}im pan-
encefalitisom (SSPE) u Hrvatskoj tijekom 2002 godine. Dob bolesnika iznosila je od 5–11 godina. Svi su bolesnici re-
dovno cijepljeni protiv morbila (Morbili-Parotitis-Rubela cjepivo). Dvoje bolesnika je imalo anamnesti~ki podatak o
preboljelim morbilima u dobi od {est odnosno sedam mjeseci. U druga je dva bolesnika bolest po~ela neposredno nakon
preboljelih vodenih kozica. Titar komplement-fiksiraju}ih protutijela na virus morbila (MV) iznosio je od 1:1024 do
1:65536 u serumu te od 1:16 do 1:128 u cerebrospinalnom likvoru (CSL). Protutijela na virus varicella-zoster u CSL
nisu na|ena. Postmortalno su dobiveni uzorci mo`danog tkiva od dvoje bolesnika. U jednog je bolesnika elektronska
mikroskopija pokazala intranuklearne virusne inkluzije (MV nukleokapside). Metodom IFA, MV antigen dokazan je u
mo`danom otisku u oba bolesnika. Virusna RNA na|ena je samo u uzorcima mo`danog tkiva, dok su plazma, serum i
CSL bili negativni. Analizom sekvenci nukleotida dokazan je divlji tip MV D6 genotipa14.
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